MannKind stock dips on report of 2020 losses, but company touts fourth quarter comeback
MannKind Corp. struggled during 2020, but impressive financial results from its final quarter could be a sign of good things to come for the Westlake Village biotech company. MannKind, which develops drugs and treatments for those suffering from diabetes and pulmonary arterial hypertension, reported a net loss of $57.2 million in fiscal year 2020, up Read More →
Read More →Inogen announces net loss, predicts better 2021
Goleta-based Inogen reported declines in both revenue and net income due to the COVID-19 pandemic on Feb. 24, when the maker of portable oxygen concentrators released its financial results for the fourth quarter and full year of 2020. Total revenue for the fourth quarter was $74 million, a decline of 6.3% from the same quarter Read More →
Read More →Santa Maria farm pays $30k to workers to settle labor complaint
More than 200 Santa Maria farmworkers received settlement checks from Rancho Laguna Farms on Feb. 21, a day after the farm agreed to a $30,000 informal settlement of an unfair labor practice charge with the California Agricultural Labor Relations Board. The board distributed checks to 212 farmworkers at the Central Coast United for a Sustainable Read More →
Read More →UCSB green-tech spinout C-Zero closes $11.5M round
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →